Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Steven O'Day"'
Autor:
Andrea Bullock, Justin Moser, Daruka Mahadevan, Michael Gordon, Przemyslaw Twardowski, Apostolia Tsimberidou, Breelyn Wilky, Waldo Ortuzar Feliu, Anthony El-Khoueiry, Steven O’Day, Bruno Bockorny, Katherine Rosenthal
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/e5ddc153157d45b0bd1cab923730850e
Autor:
Geoffrey Gibney, Ari VanderWalde, Joanne Xiu, Joseph Drabick, Gino In, Steven O’Day, Kelsey Poorman, W Korn
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/25ea86b76a7443538df69b5b1ae74b2f
Autor:
F. Stephen Hodi, Rachel Humphrey, Geoffrey Nichol, Oliver Bohnsack, Michael Binder, Michele Maio, Celeste Lebbé, Omid Hamid, Jeffrey S. Weber, Steven O'Day, Axel Hoos, Jedd D. Wolchok
Purpose: Immunotherapeutic agents produce antitumor effects by inducing cancer-specific immune responses or by modifying native immune processes. Resulting clinical response patterns extend beyond those of cytotoxic agents and can manifest after an i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c4478970fcd76651243c3b3a282a13b
https://doi.org/10.1158/1078-0432.c.6517623.v1
https://doi.org/10.1158/1078-0432.c.6517623.v1
Autor:
Georgina V. Long, Richard Kefford, Peter F. Lebowitz, Martin Curtis, Robert Gagnon, Bo Ma, Michael A. Davies, Anna Pavlick, Michael P. Brown, Michael Millward, Hendrik-Tobias Arkenau, Gerald S. Falchook, Jeffrey R. Infante, Steven O'Day, Kurt D'Andrea, Richard Letrero, Joel Greshock, Bradley Wubbenhorst, Anne-Marie Martin, Katherine L. Nathanson
Supplementary Table 1 - PDF file 54K, Patient description with tumor PTEN status available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65424ccdf7854e6839a7479b3ac10a1e
https://doi.org/10.1158/1078-0432.22450214.v1
https://doi.org/10.1158/1078-0432.22450214.v1
Autor:
Georgina V. Long, Richard Kefford, Peter F. Lebowitz, Martin Curtis, Robert Gagnon, Bo Ma, Michael A. Davies, Anna Pavlick, Michael P. Brown, Michael Millward, Hendrik-Tobias Arkenau, Gerald S. Falchook, Jeffrey R. Infante, Steven O'Day, Kurt D'Andrea, Richard Letrero, Joel Greshock, Bradley Wubbenhorst, Anne-Marie Martin, Katherine L. Nathanson
Suppementary Table 4 - PDF file 38K, Correlation analysis of selected genes from aCGH data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::858c8d80effae65e1f2b10d9b7dca015
https://doi.org/10.1158/1078-0432.22450226.v1
https://doi.org/10.1158/1078-0432.22450226.v1
Autor:
Georgina V. Long, Richard Kefford, Peter F. Lebowitz, Martin Curtis, Robert Gagnon, Bo Ma, Michael A. Davies, Anna Pavlick, Michael P. Brown, Michael Millward, Hendrik-Tobias Arkenau, Gerald S. Falchook, Jeffrey R. Infante, Steven O'Day, Kurt D'Andrea, Richard Letrero, Joel Greshock, Bradley Wubbenhorst, Anne-Marie Martin, Katherine L. Nathanson
Supplementary Table 2 - PDF file 42K, Correlation of PTEN immunohistochemistry and PTEN mutation/copy number status
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c4cb775379897c7f7d4f2fad5ee0e8e
https://doi.org/10.1158/1078-0432.22450211.v1
https://doi.org/10.1158/1078-0432.22450211.v1
Autor:
Georgina V. Long, Richard Kefford, Peter F. Lebowitz, Martin Curtis, Robert Gagnon, Bo Ma, Michael A. Davies, Anna Pavlick, Michael P. Brown, Michael Millward, Hendrik-Tobias Arkenau, Gerald S. Falchook, Jeffrey R. Infante, Steven O'Day, Kurt D'Andrea, Richard Letrero, Joel Greshock, Bradley Wubbenhorst, Anne-Marie Martin, Katherine L. Nathanson
Purpose: Dabrafenib is a selective inhibitor of V600-mutant BRAF kinase, which recently showed improved progression-free survival (PFS) as compared with dacarbazine, in metastatic melanoma patients. This study examined potential genetic markers assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c834bb070142a1c0fe1ff249a242261a
https://doi.org/10.1158/1078-0432.c.6521879
https://doi.org/10.1158/1078-0432.c.6521879
Autor:
Georgina V. Long, Richard Kefford, Peter F. Lebowitz, Martin Curtis, Robert Gagnon, Bo Ma, Michael A. Davies, Anna Pavlick, Michael P. Brown, Michael Millward, Hendrik-Tobias Arkenau, Gerald S. Falchook, Jeffrey R. Infante, Steven O'Day, Kurt D'Andrea, Richard Letrero, Joel Greshock, Bradley Wubbenhorst, Anne-Marie Martin, Katherine L. Nathanson
Supplementary Figure 2 - PDF file 252K, Copy number in baseline samples comparing patients with V600E vs. V600K mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e1bfaf3df30969b630b65191adbb8b6
https://doi.org/10.1158/1078-0432.22450220.v1
https://doi.org/10.1158/1078-0432.22450220.v1
Autor:
Georgina V. Long, Richard Kefford, Peter F. Lebowitz, Martin Curtis, Robert Gagnon, Bo Ma, Michael A. Davies, Anna Pavlick, Michael P. Brown, Michael Millward, Hendrik-Tobias Arkenau, Gerald S. Falchook, Jeffrey R. Infante, Steven O'Day, Kurt D'Andrea, Richard Letrero, Joel Greshock, Bradley Wubbenhorst, Anne-Marie Martin, Katherine L. Nathanson
Supplementary Methods - PDF file 95K, Supplementary Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::467c6f7cb3cf32a3ee047b261f92ed52
https://doi.org/10.1158/1078-0432.22450217.v1
https://doi.org/10.1158/1078-0432.22450217.v1
Autor:
Georgina V. Long, Richard Kefford, Peter F. Lebowitz, Martin Curtis, Robert Gagnon, Bo Ma, Michael A. Davies, Anna Pavlick, Michael P. Brown, Michael Millward, Hendrik-Tobias Arkenau, Gerald S. Falchook, Jeffrey R. Infante, Steven O'Day, Kurt D'Andrea, Richard Letrero, Joel Greshock, Bradley Wubbenhorst, Anne-Marie Martin, Katherine L. Nathanson
Supplementary Figure 1 - PDF file 214K, Copy number in baseline samples from patients with partial response compared to those with stable or progressive disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::463b1883522f977a1bcd3320818434d0
https://doi.org/10.1158/1078-0432.22450223.v1
https://doi.org/10.1158/1078-0432.22450223.v1